|
ATC Workshop Papers
From Cell to Production
Technical Challenges of Cloning Pigs for BioMedical
Research
Somatic Cell Nuclear Transfer in Mammals
SATACs and Transgenesis
Concerns About Gene Transfer and Nuclear Transfer
in Domestic Animals
Prospects and Hurdles in Optimizing the Vascular
Support of Engineered Tissues
ES Cells Make Neurons in a Dish
Nuclear Transfer and Gene Targeting in Domestic
Animals: Bioreactors of the Future
Application of Nuclear Transfer Technology
in the Generation of Pigs for Xenetransplantation
Genomics: Delivering Cell Culture Systems
for Tissue Therapy
Nuclear Transfer Technology
Homologous Recombination and Genetic Engineering
of Transgenic Recombinant Animals
Nuclear Transplantation in the Cow: Future
Challenges
Enhancing Transgenics through Cloning
ES Cells Offer is a Power Tool for Understanding
the Genetic Control of Tissue Development and for Screening Potential
Therapeutic Drugs
Human Germline Engineering -- The Prospects
for Commercial Development
Mammalian Artificial Chromosomes for Animal
Transgenesis
Understanding Developmental Abnormalities
in Offspring Produced by Nuclear Transplantation
Role of Cell Cycle
Cloning and Other Reproductive Technologies
for Application in Transgenics
Cell Culturing Technology as a Major Hurdle
in the Commercialization of Genetically Altered Animals
|
| ADVANCED TRANSGENESIS AND
CLONING: Genetic Manipulation in Animals
Electronic Workshop Presentation: Paper
No. 12
GENE TARGETING IN THE PORCINE AND
BOVINE SPECIES: CHALLENGES AND OPPORTUNITIES
Participant:
Jorge A. Piedrahita
Center for Animal Biotechnology
Texas A&M University
College Station, TX. 77843
In contrast to the highly developed genetic
modification systems available for manipulating the mouse genome,
at this time only simple gain of function modifications can be readily
undertaken in domestic species. This is due to the limited concerted
effort in developing gene targeting technology in domestic species,
as well as technical barriers unique to the bovine and porcine.
Clearly the greatest barrier to gene targeting in these two species
is the unavailability of cell lines that can be readily modified
in vitro and still be used to generate a living organism. In the
mouse, the embryonic stem (ES) cells and embryonic germ (EG) cells
have fulfilled that role. In addition to the absence of easily manipulated
cell lines, targeting in the bovine and porcine species is affected
by the need to develop targeting constructs containing isogenic
DNA regions. As a result it is not possible to generate genomic
libraries from a particular breed, and isolate genes from that library
to develop effective targeting constructs. Instead, it is necessary
to isolate the gene of interest, sequence required regions, and
develop isogenic targeting constructs by technologies such as long-range
PCR, thus increasing the time frame and costs required to develop
a targeting construct.
With regards to pluripotent/totipotent cell lines, in spite of
considerable efforts it has not been possible to establish ES cell
lines in the bovine and porcine that can be used to introduce genetic
modifications into the germ line. Fortunately, in the case of the
bovine species, advances in cloning by nuclear transfer indicate
that fetal fibroblasts can be manipulated in vitro and still be
used to generate a normal offspring. In order to test the use of
fibroblasts as targets for homologous recombination we isolated
the bovine PrP gene, and obtained sequence information necessary
for generation of targeting constructs. Utilizing isogenic DNA,
targeting constructs were made and introduced into fetal fibroblasts
by electroporation. Transgenic colonies are being analyzed for the
presence of the targeted allele. By far the greatest problem affecting
the outcome of this experiment is the inability to maintain the
fetal fibroblasts in a proliferative state for longer than 25-30
doublings. This, combined with the lower targeting efficiency of
somatic cells versus embryonic stem cells, makes identification
of targeted clones extremely difficult. It is clear, therefore,
that for wide applicability of the technology cell lines that can
be used for the cloning procedure but can also be cultured for greater
than 30 doublings are required. Alternately, gene targeting system
of much greater efficiency than the existing ones need to be developed
to ensure than even with a limited cellular life span, targeted
events are identified.
Although it is likely that the cloning procedure will soon be applicable
to swine, at this time the only available option for precise genetic
modification in this species is the use of EG cell lines. Recently,
we have been able to isolate EG cells from swine, and utilize them
for the generation of transgenic chimeras. While these cell lines
may be of use as carrier systems, they are difficult to maintain,
have low cloning efficiency, and require the generation of chimeras
before a founder can be established; an additional generation that
can have significant economic impact in species with relatively
long gestation and reproductive maturity periods. However, in contrast
to fetal fibroblast, they do not readily undergo senescence and
can be maintained for prolonged periods of time, although with some
loss of undifferentiated characteristics. Additionally, they may
be of use for favoring entrance into the germ line by use of tetraploid
embryos for chimera generation, or by using the cells as nuclear
donors in a cloning procedure.
While at this time the greatest barriers to the application of
this technology are mostly technical, it is likely that with a concerted
effort and federal support most if not all of these barriers will
soon be overcome. Thus, it is critical that in parallel with efforts
to complete development of the technology, efforts to identify single
genes that can have significant economic impact in phenotypes of
agricultural importance, such as muscle composition and disease
resistance, must be supported. Otherwise, we run the risk of ending
up with a technique for manipulating genes but no genes to manipulate.
|